Patient Misdiagnosed with Lyme Disease

One man went in with various symptoms and was told he had Lyme disease when in fact he had non-Hodgkin's lymphoma:

"For patients who have no answers after bouncing from doctor to doctor, physicians who diagnose and treat chronic Lyme disease can become heroes.

Phillip Moore initially felt that way about Dr. Joseph Jemsek, who in 2004 diagnosed Moore with Lyme in North Carolina. "He made you feel like he was the only person on the planet that was going to make you better and save you," Moore said.

But Moore now says he feels duped. After enduring intravenous antibiotic treatments that made him so sick he had to take a three-month leave from his job, Moore learned from a different doctor that his tests and clinical history showed he didn't have Lyme disease. This year, Moore was told he had a rare form of non-Hodgkin's lymphoma and that the cancer had spread."

Read More: http://www.dc50tv.com/health/la-he-lyme-disease-side2-20101227,0,1802711...

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap